To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.

Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

Status: Active, not recruiting

Conditions: Peptic Ulcer; Gastritis Chronic; Gastroduodenitis; Duodenal Ulcer

Treatments: Drug: Enteral oxygen therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT04702542

TashkentPediatricMI-2

Details and patient eligibility

About

The object of the study will be children and adolescents from 6 to 15 years old, living in the city of Tashkent and in the Tashkent region. We will study patients with various clinical forms of chronic gastroduodenal pathology (CGDP). The effect of enteral oxygen therapy in the recovery of patients with CGDP due to the positive effect of the active form of oxygen on the hematological system and on the regenerative processes in the gastrointestinal tract will be studied. At the same time, the effect of enteral oxygen therapy on enhancing the effectiveness of eradication therapy during the treatment of carrier Helicobacter pylori due to the neutralization of the products of urea hydrolysis around bacteria under the action of reactive oxygen species will be studied.

Full description

In recent years, among the non-infectious diseases of children and adolescents, there has been an increase in many nosological forms of pathology of the gastrointestinal tract. Scientific works of recent years show that all over the world much attention is paid to the problem of timely prevention and improvement of chronic diseases of the gastroduodenal zone in children. This is mainly due to the fact that the incidence of diseases of the digestive system among schoolchildren is steadily increasing. In the clinical practice of gastroenterologists, it is often necessary to influence the regeneration processes in the gastroduodenal zone. The object of the study will be children and adolescents from 6 to 15 years old, living in the city of Tashkent and in the Tashkent region. We will study patients with various clinical forms of chronic gastroduodenal pathology (CGDP). The effect of enteral oxygen therapy in the recovery of patients with CGDP due to the positive effect of the active form of oxygen on the hematological system and on the regenerative processes in the gastrointestinal tract will be studied. At the same time, the effect of enteral oxygen therapy on enhancing the effectiveness of eradication therapy during the treatment of carrier Helicobacter pylori due to the neutralization of the products of urea hydrolysis around bacteria under the action of reactive oxygen species will be studied.

Enrollment: 320 estimated patients

Sex: All

Ages: 6 to 15 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• children and adolescents aged 6 to 15 years;
• children with chronic gastroduodenal pathology: chronic gastritis, chronic gastroduodenitis, chronic duodenitis, gastric and intestinal ulcers of both sexes;
• children who have the opportunity to visit the clinic.

Exclusion criteria

• children under 6 years old and adolescents over 15 years old;
• children with chronic diseases of internal organs, except for the gastrointestinal tract;
• children with psychosomatic and neurological disorders;
• children in hospital;
• children with endocrine diseases;
• children who are allergic to eggs;
• children with blood diseases;
• children with cancer.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

320 participants in 1 patient group

Enteral oxygen therapy for the improvement of children with chronic gastroduodenal pathology.

Experimental group

Description:

Enteral oxygen therapy is prescribed for children with chronic gastroduodenal pathology during the recovery period, after inpatient treatment, for 14 days, every day, in the form of an oxygen cocktail. An oxygen cocktail is prepared on the basis of a pharmaceutical product using herbal ingredients. The patient takes a 200 ml oxygen cocktail. using a small spoon, during the daytime.

Treatment:

Drug: Enteral oxygen therapy